Solomon R, Barrett B
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont 05401, USA.
Kidney Int Suppl. 2006 Apr(100):S46-50. doi: 10.1038/sj.ki.5000374.
In this chapter, we review the approach to following the patient after contrast is administered. We first discuss the clinical importance of renal injury for if there were no clinically significant consequences of this renal injury, we would have far less concern for the adequacy of follow-up. We next look at markers of renal injury and what tests are used in clinical practice to define contrast-induced nephropathy (CIN). Finally, we discuss the steps that should be taken in those who do develop CIN to limit the impact of the injury and protect them from future adverse events.
在本章中,我们回顾了造影剂注射后对患者进行随访的方法。我们首先讨论肾损伤的临床重要性,因为如果这种肾损伤没有临床上的显著后果,我们对随访充分性的担忧就会少得多。接下来,我们将探讨肾损伤的标志物以及临床实践中用于定义造影剂肾病(CIN)的检查。最后,我们讨论对于发生CIN的患者应采取哪些措施,以限制损伤的影响并保护他们免受未来不良事件的影响。